Cost-effectiveness of zoledronic acid and strontium-89 as bone protecting treatments in addition to chemotherapy in patients with metastatic castrate-refractory prostate cancer. (ISRCTN 12808747) TRAPEZE
Abstract only
Saved in:
Published in | Journal of clinical oncology Vol. 33; no. 15_suppl; p. e16108 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
20.05.2015
|
Online Access | Get full text |
Cover
Loading…
Summary: | Abstract only |
---|---|
ISSN: | 0732-183X 1527-7755 |
DOI: | 10.1200/jco.2015.33.15_suppl.e16108 |